限制性液体复苏联合连续性肾脏替代治疗在重症急性胰腺炎并发腹腔间隔室综合征治疗中的应用价值

Application value of limited liquid resuscitation combined with continuous renal replacement therapy in treatment of severe acute pancreatitis companied with abdominal compartment syndrome

  • 摘要: 目的:探讨限制性液体复苏联合连续性肾脏替代治疗(CRRT)在重症急性胰腺炎(SAP)合并腹腔间隔室综合征(ACS)患者治疗中的应用价值。
    方法:采用回顾性队列研究方法。收集2005年1月至2014年12月重庆市涪陵中心医院收治的67例SAP并发ACS患者的临床资料,2005年1月至2010年12月收治33例患者采用常规液体复苏治疗设为对照组,2011年1月至2014年12月收治34例患者采用限制性液体复苏联合CRRT设为观察组。观察指标:(1)两组患者所需液体量及负平衡时间。(2)两组患者治疗后病理生理指标的变化。(3)两组患者的结局与预后。正态分布的计量资料以±s表示,组间比较采用t检验。计数资料采用x2检验。重复测量数据采用重复测量方差分析。
    结果:(1)两组患者所需液体量及负平衡时间:对照组患者复苏6、24、48和72 h所需液体量分别为(2 449±339)mL、(4 820±757)mL、(9 428±1 272)mL、(13 127±1 565)mL,观察组上述指标分别为(2 360±314)mL、(4 582±530)mL、(8 564±970)mL、(11 470±1 253)mL,两组患者所需液体量比较,差异有统计学意义(F=13.035,P<0.05),其中复苏48 h和72 h所需液体量比较,差异均有统计学意义(t=3.132,4.794,P<0.05)。观察组和对照组负平衡时间分别为(4.3±1.7)d和(6.4±1.8)d,两组比较,差异有统计学意义(t=4.913,P<0.05)。(2)两组患者治疗后病理生理指标的变化:时间因素:治疗0 h至治疗168 h对照组患者的急性生理与慢性健康评分Ⅱ(APACHE Ⅱ)、C反应蛋白(CRP)、D二聚体、腹内压、血乳酸、氧合指数分别由(20.9±4.1)分变化为(13.9±2.6)分,(167±39)mg/L变化为(55±17)mg/L,(1 652±1 544)μg/L变化为(993±500)μg/L,(23.4±3.4)cmH2O(1 cmH2O=0.098 kPa)变化为(21.4±2.9)cmH2O,(4.6±1.6)mmol/L变化为(1.4±0.5)mmol/L,(189±27)mmHg(1 mmHg=0.133 kPa)变化为(152±23)mmHg;观察组患者上述指标分别由(21.5±5.1)分变化为(11.0±2.8)分,(168±36)mg/L变化为(44±19)mg/L,(1 634±1 525)μg/L变化为(578±350)μg/L,(23.2±2.5)cmH2O变化为(17.4±2.6)cmH2O,(4.5±1.6)mmol/L变化为(0.8±0.3)mmol/L,(188± 26)mmHg变化为(196±25)mmHg,两组患者上述指标随着时间的增加逐渐降低,差异均有统计学意义(F=186.415,581.118,34.618,212.416,262.272,207.645,P<0.05)。处理因素:对照组和观察组患者APACHE Ⅱ评分、D二聚体、血乳酸变化趋势比较,差异均无统计学意义(F=3.499,2.350,3.516,P>0.05);对照组和观察组患者CRP、腹内压、氧合指数变化趋势比较,差异均有统计学意义(F=4.009,15.276,14.959,P<0.05)。处理因素与时间因素交互效应:APACHE Ⅱ评分、CRP、腹内压、氧合指数处理因素与时间因素交互效应明显(F=4.890,4.912,23.874,28.615,P<0.05),D二聚体、血乳酸无处理因素与时间因素交互效应(F=2.803,1.920,P>0.05)。(3)两组患者的结局与预后:对照组患者手术、局部并发症、感染发生例数以及住院时间分别为11、16、14例和(46±17)d,观察组上述指标分别为4、6、6例和(36±14)d,两组患者上述指标比较,差异均有统计学意义(x2=4.484,7.221,4.910,t=2.433,P<0.05)。对照组患者病死率和住院费用分别为24.2%(8/33)和(33±18)万元,观察组上述指标分别为8.8%(3/34)和(27±14)万元,两组患者上述指标比较,差异均无统计学意义(x2=2.901,t=1.283,P>0.05)。
    结论:限制性液体复苏联合CRRT可有效控制SAP合并ACS患者腹内压,改善患者氧合指数;对减少手术、感染、局部并发症以及住院时间有益

     

    Abstract: Objective:To investigate the application value of limited liquid resuscitation combined with continuous renal replacement therapy (CRRT) in treatment of severe acute pancreatitis (SAP) companied with abdominal compartment syndrome (ACS).
    Methods:The retrospective cohort study was adopted. The clinical data of 67 patients with SAP companied with ACS who were admitted to the Fuling Center Hospital of Chongqing from January 2005 to December 2014 were collected. Among 67 patients, 33 receiving conventional liquid resuscitation between January 2005 and December 2010 were allocated into the control group and 34 receiving limited liquid resuscitation combined with CRRT between January 2011 and December 2014 were allocated into the observation group. Observation indicators included: (1) required fluid volume and time of negative fluid balance in the 2 groups; (2) changes of pathological and physiological indicators after treatment in the 2 groups; (3) outcomes and prognosis of patients in the 2 groups. Measurement data with normal distribution were represented as ±s and comparison between groups was analyzed using t test. Count data were analyzed using the chisquare test. Repeated measurement data were analyzed by repeated measures ANOVA.
    Results:(1) Required fluid volume and time of negative fluid balance in the 2 groups: required fluid volumes at 6, 24, 48 and 72 hours after resuscitation were (2 449±339)mL,(4 820±757)mL,(9 428±1 272)mL, (13 127±1 565)mL in the control group and (2 360±314)mL, (4 582±530)mL, (8 564±970)mL, (11 470±1 253)mL in the observation group, respectively, with a statistically significant difference in required fluid volume between the 2 groups (F=13.035, P<0.05) and in required fluid volume at 48 and 72 hours between the 2 groups (t=3.132, 4.794, P<0.05). Time of negative fluid balance in the observation group and control group was (4.3±1.7)days and (6.4± 1.8)days, respectively, showing a statistically significant difference between the 2 groups (t=4.913, P<0.05). (2) Changes of pathological and physiological indicators in the 2 groups after treatment: time factors: from 0 h to 168 h postoperatively, APACHE Ⅱ score, Creaction protein (CRP), Ddimer, IAP, Bla and oxygenation index were changed from 20.9±4.1 to 13.9±2.6,from (167±39)mg/L to (55±17)mg/L, from (1 652±1 544)μg/L to (993±500)μg/L, from (23.4±3.4)cmH2O (1 cmH2O=0.098 kPa) to (21.4±2.9)cmH2O, from (4.6± 1.6)mmol/L to (1.4±0.5)mmol/L, from (189±27)mmHg (1 mmHg=0.133 kPa) to (152±23)mmHg in the control group, and chaged from 21.5±5.1 to 11.0±2.8, from (168±36)mg/L to (44±19)mg/L, from (1 634±1 525)μg/L to (578±350)μg/L, from (23.2±2.5)cmH2O to (17.4±2.6)cmH2O, from (4.5±1.6)mmol/L to (0.8±0.3)mmol/L, from (188±26)mmHg to (196±25)mmHg in the observation group, respectively, showing gradual decreasing with time and statistically significant differences between the 2 groups (F=186.415, 581.118, 34.618, 212.416, 262.272, 207.645, P<0.05). Treatment factors: there were no significant differences in changing trends of APACHE Ⅱ score, Ddimer and Bla between the 2 groups (F=3.499, 2.350, 3.516, P>0.05), and there were significant differences in changing trends of CRP, IAP and oxygenation index between the 2 groups (F=4.009, 15.276, 14.959, P<0.05). Interaction effect between time factors and treatment factors: there were obviously interaction effects between time factors and treatment factors in APACHE Ⅱ score, CRP, IAP and oxygenation index (F=4.890, 4.912, 23.874, 28.615, P<0.05) and no interaction effects between time factors and treatment factors in Ddimer and Bla (F=2.803, 1.920, P>0.05). (3) Outcomes and prognosis of patients in the 2 groups: numbers of patients with surgery, local complications and infection and duration of hospital stay were 11, 16, 14, (46±17)days in the control group and 4, 6, 6, (36±14)days in the observation group, respectively, with statistically significant differences between the 2 groups (x2=4.484, 7.221, 4.910, t=2.433, P<0.05). Mortality and hospital expenses were 24.2%(8/33), (33±18)×104 yuan in the control group and 8.8%(3/34), (27±14)×104 yuan in the observation group, respectively, with no statistically significant difference between the 2 groups (x2=2.901, t=1.283, P>0.05).
    Conclusion:Limited liquid resuscitation combined with CRRT can effectively control IAP of patients with SAP companied with ACS and improve oxygenation index, meanwhile, it can also reduce number of patients with surgery, infection and local complications and duration of hospital stay.

     

/

返回文章
返回